Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 21, 2022; 28(15): 1574-1587
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1574
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1574
Figure 1 Patient flowchart.
Figure 2 Kaplan-Meier curves of ICC recurrence: Time after surgery.
ICC: Intrahepatic cholangiocarcinoma; MS: Median survival.
Figure 3 Kaplan-Meier curves of ICC recurrence: Time after recurrence.
ICC: Intrahepatic cholangiocarcinoma; MS: Median survival.
Figure 4 Venn diagram of recurrent location pattern.
Intrahepatic lesions (25/54, 46.3%) were the most common recurrence sites, followed by concurrent liver and lymph nodes (13/54, 24.1%).
Figure 5 Kaplan-Meier curves of ICC recurrence: multimodality therapy versus no multimodality therapy.
Patients with recurrent ICC who received multimodality therapy had a significantly better long-term survival after recurrence than those who did not (P = 0.026, log-rank test). ICC: Intrahepatic cholangiocarcinoma; MS: Median survival.
- Citation: Yuan ZB, Fang HB, Feng QK, Li T, Li J. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study. World J Gastroenterol 2022; 28(15): 1574-1587
- URL: https://www.wjgnet.com/1007-9327/full/v28/i15/1574.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i15.1574